After an early career as
a General and Colorectal Surgeon Wynne joined
E R
Squibb (now Bristol-Myers Squibb) as Associate
Director of Clinical Research
and has subsequently spent 23 years in the
pharmaceutical and biotechnology
industries. During this time he has worked
or consulted on clinical, nonclinical
and regulatory affairs
for many of the world’s major healthcare companies.
Before co-founding Polymed he spent eight years as
Medical and Development Director of a UK biotechnology
company during which he took novel biological drugs
from discovery through late Phase II clinical trials
in Europe and North America. Wynne is also a Non-Executive
Director of Healthcare Holdings plc, which floated
on AIM in March 2004
Frank Arnold Medical
Director
Frank gained the Fellowship
of the Royal College of Surgeons in England
and
worked in General and Cardiovascular Surgery
before developing a special
interest in the healing of chronic wounds.
He has held Research Fellowships
at the School of Biological Sciences, University
of Manchester and at the
Institute for Wound
Healing at the University of Oxford. He has an extensive
list before co-founding Polymed he spent eight years
as Medical and Development Director of a UK biotechnology
company during which he took novel biological drugs
from discovery through late Phase II clinical trials
in Europe and North America. Wynne is also a Non-Executive
Director of Healthcare Holdings plc, which floated
on AIM in March 2004
Brian Head Commercial
Director
Brian holds an MBA from
Cass Business School in the City of London.
He has
worked in various City financial institutions,
in pharmaceutical business
development at GSK and has consulted for early
phase and start up companies
where he has advised on business development,
managed multi-discipline
projects and supported
multiple business heads. Brian provides essential
commercial, financial and project management expertise
to the Polymed skill set
